Britain says pushing for better outcome on US pharma tariffs

Core Viewpoint - Britain is actively engaging with the United States regarding pharmaceutical tariffs, aiming for a favorable resolution after President Trump announced a potential 100% tariff on companies unless they establish manufacturing operations in the U.S. [1] Group 1 - The British government is pressing the U.S. on pharmaceutical tariffs [1] - President Trump indicated that a new 100% tariff would be imposed on firms without a manufacturing presence in the U.S. [1]